Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF)
申请人:Pfizer Inc
公开号:US06262040B1
公开(公告)日:2001-07-17
The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R, R1, and R2, are as defined herein. The invention further relates to pharmaceutical compositions containing, and methods of using, the compounds of formula (I), or acceptable salts thereof, for the inhibition of phosphodiesterase (PDE) type IV or the production of tumor necrosis factor (TNF) in a mammal. The invention also relates to intermediates that are useful in the preparation of the compounds of formula (I).
这项发明涉及式(I)的化合物及其药用盐,其中R、R1和R2如本文所定义。该发明还涉及含有该式(I)的化合物的药物组合物,以及使用该化合物或其可接受的盐来抑制磷酸二酯酶(PDE) IV型或在哺乳动物体内产生肿瘤坏死因子(TNF)的方法。该发明还涉及在制备该式(I)的化合物中有用的中间体。